Health Canada Authorizes Clinical Trial for Cellulose-Based Dermal Filler
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
The cellulose-based dermal filler has received Health Canada authorization to begin clinical trials evaluating its safety and performance in tissue augmentation.
Allergan Aesthetics’ Heidi Shurtz discusses updates to the APP loyalty program, including simplified savings, greater pricing transparency, and new benefits for growing aesthetics practices.